Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019488 220007766 1.52 0 Disease modification (D) 2017-08-28 2017-10-11 IDARUBICIN + TRETINOIN 2 N 220029889 IDARUBICIN + TRETINOIN
220019489 220021531 1.68 113.8 Curative (C) 2018-10-01 2018-10-01 ATG + Busulfan + Fludarabine N null 220029900 ATG + BUSULFAN + FLUDARABINE
220019490 220007770 null 52.5 Curative (C) 2018-08-13 2018-08-23 IDARUBICIN + TRETINOIN N N 220029903 IDARUBICIN + TRETINOIN
220019491 220007772 1.76 60 Disease modification (D) 2013-10-06 2013-12-21 Cyclophosphamide+Fludara+TBI Allo 2 N 220029906 CYCLOPHOSPHAMIDE + FLUDARABINE
220019492 220007776 1.67 60 Curative (C) 2018-01-25 2018-01-25 Methotrexate intrathecal 02 null 220029943 METHOTREXATE INTRATHECAL
220019493 220007783 null null Curative (C) 2014-08-27 2014-08-27 ATG + Busulfan + Fludarabine null N 220029966 ATG + BUSULFAN + FLUDARABINE
220019494 220007789 1.84 71.8 Curative (C) 2014-08-21 2014-11-30 Idarubicin+Tretinoin Spanish Crse4 N N 220029989 IDARUBICIN + TRETINOIN
220019495 220007793 1.68 55.1 Curative (C) 2015-09-04 2015-09-20 FLAG N N 220029995 FLAG
220019496 220007794 null 72.5 Curative (C) null 2017-11-06 ATG + Busulfan + Fludarabine null N 220030009 ATG + BUSULFAN + FLUDARABINE
220019497 220007795 1.59 0 Curative (C) 2017-04-24 2017-04-24 FLAG Y N 220030022 FLAG
220019498 220007798 null null Curative (C) 2016-06-20 2016-08-28 Triple Intrathecal N null 220030037 TRIPLE INTRATHECAL
220019499 220007804 1.76 107.5 Curative (C) 2017-05-22 2017-05-22 Methotrexate intrathecal N N 220030047 METHOTREXATE INTRATHECAL
220019500 220014300 1.65 68.8 Curative (C) 2018-01-02 2018-02-13 Idarubicin+Tretinoin Spanish Crse1 02 Y 220030066 IDARUBICIN + TRETINOIN
220019501 220007819 1.6 66 Curative (C) 2016-08-09 2016-10-31 AML16 DA 3+10 N N 220030073 AML16 TRIAL
220019502 220017804 1.52 null Not known (9) 2017-04-19 2017-05-29 AML Int Guide ADE 8+3+5 (2) N N 220030089 ADE
220019503 220014305 1.63 89.6 Disease modification (D) null 2016-08-04 IDARUBICIN + TRETINOIN null N 220030092 IDARUBICIN + TRETINOIN
220019504 220007825 1.57 61.35 Curative (C) 2013-10-11 2013-12-01 CYCLOPHOSPHAMIDE + FLUDARABINE 2 N 220030099 CYCLOPHOSPHAMIDE + FLUDARABINE
220019505 220007828 1.66 102 Disease modification (D) 2014-02-25 2014-03-23 Methotrexate intrathecal N N 220030109 METHOTREXATE INTRATHECAL
220019506 220014309 1.41 null Curative (C) 2016-02-01 2016-02-01 IDARUBICIN + TRETINOIN N null 220030109 IDARUBICIN + TRETINOIN
220019507 220014310 1.65 null Curative (C) 2016-03-10 2016-05-03 CYCLOPHOSPHAMIDE 2 N 220030114 CYCLOPHOSPHAMIDE
220019508 220007833 1.8 82 Disease modification (D) 2014-03-31 2014-04-13 BOSUTINIB N N 220030138 BOSUTINIB
220019509 220014314 null 71 Curative (C) 2015-05-13 2015-10-05 Idarubicin+Tretinoin Spanish Crse2 N N 220030142 IDARUBICIN + TRETINOIN
220019510 220007838 1.71 65 Curative (C) 2015-11-14 2015-11-24 Methotrexate intrathecal N N 220030144 METHOTREXATE INTRATHECAL
220019511 220007842 1.7 22.3 Curative (C) 2014-03-13 2014-03-13 IDARUBICIN + TRETINOIN N N 220030145 IDARUBICIN + TRETINOIN
220019512 220007845 0 67.8 Curative (C) null 2018-08-10 BOSUTINIB 2 N 220030148 BOSUTINIB
220019513 220007852 1.64 65 Disease modification (D) 2019-01-24 2019-01-24 CYCLOPHOSPHAMIDE + FLUDARABINE 2 N 220030168 CYCLOPHOSPHAMIDE + FLUDARABINE
220019514 220007857 1.8 107.7 Curative (C) 2017-01-17 2017-01-18 ATG + Busulfan + Fludarabine 2 N 220030182 ATG + BUSULFAN + FLUDARABINE
220019515 220007861 1.7 72 Curative (C) 2017-11-27 2018-04-30 Cyclophosphamide TBI Allograft Y N 220030188 CYCLOPHOSPHAMIDE
220019516 220007874 1.74 62.95 Curative (C) 2017-05-11 2017-05-18 Cyclophosphamide TBI Allograft N N 220030225 CYCLOPHOSPHAMIDE
220019517 220007879 null 71.6 Curative (C) 2017-03-13 2017-03-13 AML16 DA 3+10 N N 220030233 AML16 TRIAL
220019518 220007885 1.54 74.1 Curative (C) 2015-11-26 2016-01-30 Cyclophosphamide TBI Allograft N N 220030250 CYCLOPHOSPHAMIDE
220019520 220007893 1.58 null Adjuvant (A) 2017-06-05 2017-06-05 FLAG 02 N 220030275 FLAG
220019521 220007903 1.64 66.5 Curative (C) 2014-11-19 2016-08-08 AML16 Low Dose Cytarabine 02 N 220030293 AML16 TRIAL
220019522 220014336 1.72 95 Disease modification (D) 2014-10-20 2014-10-21 RUXOLITINIB N N 220030293 RUXOLITINIB
220019523 220007905 null null Disease modification (D) 2017-05-12 2017-05-12 AML16 DA 3+8 2 N 220030299 AML16 TRIAL
220019524 220007909 1.58 46.9 Curative (C) 2014-07-15 2014-07-17 CYCLOPHOSPHAMIDE + FLUDARABINE N null 220030302 CYCLOPHOSPHAMIDE + FLUDARABINE
220019525 220014341 1.59 59 Curative (C) null 2017-04-12 ATG + Busulfan + Fludarabine N N 220030310 ATG + BUSULFAN + FLUDARABINE
220019526 220007915 1.8 102.6 Disease modification (D) null 2015-05-24 Idarubicin+Tretinoin Spanish Crse4 02 N 220030316 IDARUBICIN + TRETINOIN
220019527 220021537 1.57 75 Curative (C) 2015-02-07 2015-05-19 Idarubicin+Tretinoin Spanish Crse4 N N 220030337 IDARUBICIN + TRETINOIN
220019528 220007926 null 82 Curative (C) 2014-02-01 2014-02-01 AML16 DA 3+8 02 N 220030339 AML16 TRIAL
220019529 220007929 1.83 81.4 Curative (C) 2013-04-19 2014-01-01 AML16 DA 2+5 N N 220030353 AML16 TRIAL
220019530 220007937 1.78 71.8 Curative (C) 2015-05-21 2015-05-21 FLAG N N 220030383 FLAG
220019531 220014353 1.33 74.1 Curative (C) 2015-05-26 2015-05-26 ATG + Busulfan + Fludarabine 02 null 220030395 ATG + BUSULFAN + FLUDARABINE
220019532 220017832 1.72 80.7 Curative (C) 2014-03-18 2014-03-18 AML16 DA 3+8 Y N 220030429 AML16 TRIAL
220019533 220007944 1.7 null Curative (C) 2016-09-28 2016-11-17 ATG + Busulfan + Fludarabine null N 220030431 ATG + BUSULFAN + FLUDARABINE
220019534 220017833 1.73 107.7 Palliative (P) null 2017-11-26 AML Int Guide ADE 8+3+5 (2) N null 220030435 ADE
220019535 220007956 1.74 71 Curative (C) 2017-05-11 2017-05-13 Triple Intrathecal Y N 220030458 TRIPLE INTRATHECAL
220019536 220007959 0 106.8 Curative (C) 2014-06-21 2014-07-05 FLAG 01 N 220030466 FLAG
220019537 220007959 0 68.4 Curative (C) 2015-03-22 2015-03-22 Idarubicin+Tretinoin Spanish Crse2 02 N 220030466 IDARUBICIN + TRETINOIN
220019538 220007963 1.7 60.5 Curative (C) 2018-06-28 2018-07-14 BOSUTINIB 02 N 220030475 BOSUTINIB